Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 29, 2022 7:07 AM 2 min read

Vaxart And 3 Other Stocks Under $1 Insiders Are Aggressively Buying

by Lisa Levin Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

The Dow Jones settled lower by over 350 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Red Cat Holdings

  • The Trade: Red Cat Holdings, Inc. (NASDAQ:RCAT) Director, Chairman of the Board, CEO Jeffrey M Thompson bought a total of 2,000 shares at an average price of $0.84. To acquire these shares, it cost around $1.69 thousand.
  • What’s Happening: Red Cat recently reported wider-than-expected quarterly loss.
  • What Red Cat Holdings Does: Red Cat Holdings Inc provides products, services, and solutions to the drone industry.

Vaxart

Check This Out: Why Fear Level Among US Investors Is Increasing

Don’t forget to check out our premarket coverage here

Aqua Metals


Vivos Therapeutics

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Long IdeasNewsPenny StocksInsider TradesMarketsTrading IdeasPenny Stocks Insider Buying
AQMS Logo
AQMSAqua Metals Inc
$4.74-1.25%
Overview
RCAT Logo
RCATRed Cat Holdings Inc
$16.06-0.62%
VVOS Logo
VVOSVivos Therapeutics Inc
$1.350.75%
VXRT Logo
VXRTVaxart Inc
$0.7700140.0%
  • The Trade: Vaxart, Inc. (NASDAQ:VXRT) Director W. Mark Watson acquired a total of 20,000 shares at an average price of $0.76. The insider spent around $15.14 thousand to buy those shares.
  • What’s Happening: Vaxart recently named Phillip Lee as Chief Financial Officer.
  • What Vaxart Does: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases.
  • The Trade: Aqua Metals, Inc. (NASDAQ:AQMS) 10% owner Kanen Wealth Management LLC acquired a total of 283,250 shares at an average price of $0.71. To acquire these shares, it cost around $201.11 thousand.
  • What’s Happening: Aqua Metals, last month, posted a Q3 loss of $0.05 per share.
  • What Aqua Metals Does: Aqua Metals Inc is a United States-based company engaged in the business of recycling lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining.
  • The Trade: Vivos Therapeutics, Inc. (NASDAQ:VVOS) CEO R. Kirk Huntsman acquired a total of 20,000 shares at an average price of $0.50. The insider spent $10 thousand to buy those shares.
  • What’s Happening: Vivos Therapeutics recently posted a Q3 loss of $0.26 per share.
  • What Vivos Therapeutics Does: Vivos Therapeutics Inc is a medical technology company.
AQMS Logo
AQMSAqua Metals Inc
$4.74-1.25%
Overview
RCAT Logo
RCATRed Cat Holdings Inc
$16.06-0.62%
VVOS Logo
VVOSVivos Therapeutics Inc
$1.350.75%
VXRT Logo
VXRTVaxart Inc
$0.7700140.0%
Comments
Loading...